Comment from Anonymous
AnonymousSupportIndividual
Summary: An anonymous commenter supports the proposed action of adding precautionary warnings to pediatric acetaminophen labels. They argue that current safety assessments focus too heavily on liver toxicity and should instead include warnings about potential non-hepatic risks, such as reproductive, developmental, and pulmonary effects.
Please consider the attached comment in support of the precautionary case for pediatric acetaminophen warnings.
The comment addresses a broader safety concern: acetaminophen safety has historically been evaluated primarily through the lens of hepatic toxicity, but a growing body of evidence raises concern for possible non-hepatic effects, including reproductive and fertility-related endpoints, asthma/allergy associations, developing lung injury signals, and neurologic/dementia-related associations.
The relevance to pediatric use is that acetaminophen exposure during vulnerable developmental windows should not be assumed safe merely because liver toxicity is absent. If acetaminophen can affect other organ systems through oxidative stress, glutathione depletion, endocrine disruption, immune signaling, mitochondrial effects, or other non-hepatic mechanisms, then liver-only safety assumptions are inadequate for assessing risk in infants and young children.
This evidence does not require the FDA to conclude definitive causation. It supports the narrower and more appropriate precautionary conclusion that parents and clinicians should receive clearer warning language and risk communication regarding potential developmental and systemic risks associated with pediatric acetaminophen use.